Proteomics profile of cellular response to chiral drugs: Prospects for pharmaceutical applications

Proteomics

Volumn 10, Issue 4, 2010, Pages 888-893

  Ching, Chi Bun ^a   Zhang, Jianhua ^a   Sui, Jianjun ^a   Chen, Wei Ning ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

Biomedicine; Chiral drug; Chirality; Protein profile

Indexed keywords

ATENOLOL; PROPRANOLOL;

CAPILLARY ELECTROPHORESIS; CHIRALITY; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG RESEARCH; DRUG RESPONSE; ENANTIOMER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; STEREOCHEMISTRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; CELLS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; DRUG DESIGN; HUMANS; MOLECULAR CONFORMATION; PHARMACEUTICAL PREPARATIONS; PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 77149130479     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900094     Document Type: Review

References (34)

1. Wsol, V., Skalova, L., Szotakova, B., Chiral inversion of drugs: coincidence or principle? Curr. Drug Metab. 2004, 5, 517-533.
2. Yang, T. J., Yang, T. S., Liang, H. M., Thalidomide and congenital abnormalities. Lancet 1963, 1, 552-553.
3. Grinberg, N., Thompson, R., Chiral separations by HPLC, Encyclopedia of Chromatography, Taylor & Francis, London 2005, 321-326.
4. Tucker, G. T., Chiral switches. Lancet 2000, 355, 1085-1087.
5. Agranat, I. I., Caner, H., Intellectual property and chirality of drugs. Drug Discov. Today 1999, 4, 313-321.
6. Drayer, D. E., Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview. Clin. Pharmacol. Ther. 1986, 40, 125-133.
7. Waldeck, B., Three-dimensional pharmacology, a subject ranging from ignorance to overstatements. Pharmacol. Toxicol. 2003, 93, 203-210.
8. Kawamura, A., Hindi, S., Protein fishing with chiral molecular baits. Chirality 2005, 17, 332-337.
9. Arnell, R., Ferraz, N., Fornstedt, T., Analytical characterization of chiral drug-protein interactions: comparison between the optical biosensor (surface plasmon resonance) assay and the HPLC perturbation method. Anal. Chem. 2006, 78, 1682-1689.
10. Li, W., Covey, D. F., Alakoskela, J. M., Kinnunen, P. K., Steinbach, J. H., Enantiomers of neuroactive steroids support a specific interaction with the GABA-C receptor as the mechanism of steroid action. Mol. Pharmacol. 2006, 69, 1779-1782.
11. Tyers, M., Mann, M., From genomics to proteomics. Nature 2003, 422, 193-197.
12. Timperman, A. T., Aebersold, R., Peptide electroextraction for direct coupling of in-gel digests with capillary LC-MS/ MS for protein identification and sequencing. Anal. Chem. 2000, 72, 4115-4121.
13. Lilley, K. S., Razzaq, A., Dupree, P., Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Curr. Opin. Chem. Biol. 2002, 6, 46-50.
14. Kusmierz, J. J., Sumrada, R., Desiderio, D. M., Fast atom bombardment mass spectrometric quantitative analysis of methionine-enkephalin in human pituitary tissues. Anal. Chem. 1990, 62, 2395-2400.
15. Mirgorodskaya, O. A., Kozmin, Y. P., Titov, M. I., Korner, R. et al., Quantitation of peptides and proteins by matrixassisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun. Mass Spectrom. 2000, 14, 1226-1232.
16. Yao, X., Freas, A., Ramirez, J., Demirev, P. A., Fenselau, C., Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem. 2001, 73, 2836-2842.
17. Putz, S., Reinders, J., Reinders, Y., Sickmann, A., Mass spectrometry-based peptide quantification: applications and limitations. Exp. Rev. Proteomics 2005, 2, 381-392.
18. Zhang, J., Sui, J., Ching, C. B., Chen, W. N., Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics 2008, 8, 1595-1607.
19. Zapolska-Downar, D., Naruszewicz, M., Zapolski-Downar, A., Markiewski, M. et al., Ibuprofen inhibits adhesiveness of monocytes to endothelium and reduces cellular oxidative stress in smokers and non-smokers. Eur. J. Clin. Invest. 2000, 30, 1002-1010.
20. Boyd-Kimball, D., Sultana, R., Fai Poon, H., Lynn, B. C. et al., Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid [beta]-peptide (1-42) into rat brain: Implications for Alzheimer's disease. Neuroscience 2005, 132, 313-324.
21. Bristow, M. R., beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000, 101, 558-569.
22. Black, J. W., Crowther, A. F., Shanks, R. G., Smith, L. H., Dornhorst, A. C., A new adrenergic betareceptor antagonist. Lancet 1964, 1, 1080-1081.
23. Sui, J., Tan, T. L., Zhang, J., Ching, C. B., Chen, W. N., iTRAQ-coupled 2D LC-MS/MS analysis on protein profile in vascular smooth muscle cells incubated with S- and R-enantiomers of propranolol: possible role of metabolic enzymes involved in cellular anabolism and antioxidant activity. J. Proteome Res. 2007, 6, 1643-1651.
24. Sui, J., Zhang, J., Ching, C. B., Chen, W. N., Comparative proteomic analysis of extracellular proteins reveals secretion of T-kininogen from vascular smooth muscle cells in response to incubation with s-enantiomer of propranolol. Mol. Pharm. 2008, 5, 885-890.
25. Okamoto, H., Yayama, K., Shibata, H., Nagaoka, M., Takano, M., Kininogen expression by rat vascular smooth muscle cells: stimulation by lipopolysaccharide and angiotensin II. Biochim. Biophys. Acta 1998, 1404, 329-337.
26. Bhoola, K. D., Figueroa, C. D., Worthy, K., Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 1992, 44, 1-80.
27. Wu, A., Should beta-blockers still be used as initial antihypertensive agents in uncomplicated hypertension? Ann. Acad. Med. Singapore 2007, 36, 962-964.
28. Carre, A., [Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients]. Drugs 1998, 56, 23-30.
29. Sui, J., Zhang, J., Tan, T. L., Ching, C. B., Chen, W. N., Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS. Mol. Cell. Proteomics 2008, 7, 1007-1018.
30. Washburn, M. P., Wolters, D., Yates, J. R., III, Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
31. Lipton, M. S., Pasa-Tolic, L., Anderson, G. A., Anderson, D. J. et al., Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc. Natl. Acad. Sci. USA 2002, 99, 11049-11054.
32. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E. et al., Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17, 676-682.
33. Wolters, D. A., Washburn, M. P., Yates, J. R., III, An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 2001, 73, 5683-5690.
34. Han, D. K., Eng, J., Zhou, H., Aebersold, R., Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 2001, 19, 946-951.